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Background: Microbial lipid production represents a potential alternative feedstock for the biofuel and
oleochemical industries. Since Escherichia coli exhibits many genetic, technical, and biotechnological advantages
over native oleaginous bacteria, we aimed to construct a metabolically engineered E. coli strain capable of
accumulating high levels of triacylglycerol (TAG) and evaluate its neutral lipid productivity during high cell density
fed-batch fermentations.
Results: The Streptomyces coelicolor TAG biosynthesis pathway, defined by the acyl-CoA:diacylglycerol acyltransferase
(DGAT) Sco0958 and the phosphatidic acid phosphatase (PAP) Lppβ, was successfully reconstructed in an E. coli
diacylglycerol kinase (dgkA) mutant strain. TAG production in this genetic background was optimized by increasing
the levels of the TAG precursors, diacylglycerol and long-chain acyl-CoAs. For this we carried out a series of stepwise
optimizations of the chassis by 1) fine-tuning the expression of the heterologous SCO0958 and lppβ genes,
2) overexpression of the S. coelicolor acetyl-CoA carboxylase complex, and 3) mutation of fadE, the gene encoding
for the acyl-CoA dehydrogenase that catalyzes the first step of the β-oxidation cycle in E. coli. The best producing
strain, MPS13/pET28-0958-ACC/pBAD-LPPβ rendered a cellular content of 4.85% cell dry weight (CDW) TAG in
batch cultivation. Process optimization of fed-batch fermentation in a 1-L stirred-tank bioreactor resulted in
cultures with an OD600nm of 80 and a product titer of 722.1 mg TAG L
-1 at the end of the process.
Conclusions: This study represents the highest reported fed-batch productivity of TAG reached by a model
non-oleaginous bacterium. The organism used as a platform was an E. coli BL21 derivative strain containing a
deletion in the dgkA gene and containing the TAG biosynthesis genes from S. coelicolor. The genetic studies
carried out with this strain indicate that diacylglycerol (DAG) availability appears to be one of the main limiting
factors to achieve higher yields of the storage compound. Therefore, in order to develop a competitive process
for neutral lipid production in E. coli, it is still necessary to better understand the native regulation of the carbon
flow metabolism of this organism, and in particular, to improve the levels of DAG biosynthesis.
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Triacylglycerols (TAGs) are the most common lipid-based
energy reserve in animals, plants, and eukaryotic micro-
organisms [1]. These neutral lipids, traditionally sourced
from plant oils, have widespread applications in industry
and healthcare, in addition to their main use in food and* Correspondence: arabolaza@ibr-conicet.gov.ar; gramajo@ibr-conicet.gov.ar
Microbiology Division, IBR (Instituto de Biología Molecular y Celular de
Rosario), Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad
de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario,
Ocampo y Esmeralda (2000), Rosario, Argentina
© 2014 Comba et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.feed purposes. In particular, about 20% of the plant oils
produced today is utilized in certain applications of the
oleochemical industry due to the lower downstream pro-
cessing costs [2]. Furthermore, since the demand for oleo-
chemicals is expected to grow, microbial production of
free fatty acids (FAs) and FA-derived compounds such as
TAGs, waxes, alkanes, or long-chain alcohols offers a
great potential as an alternative to plant-derived products
[1,3-5]. Compared to plant oils, microbial oils have many
advantages; for example, they have a short life cycle, are
less labor intensive, are not as affected by venue, season,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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production of oils also offers the possibility to reduce the
competition with food feedstocks and the use of, for ex-
ample, cellulose, lignin, hemicellulose, CO2, or other
non-food carbon sources as raw material. Microorganisms
that naturally synthesize TAG (like species of Rhodococcus,
Mycobacterium, and Streptomyces genera) can reach high
levels of this neutral lipid under specific growth condi-
tions, as is the case of R. opaccus grown on gluconate
medium which is capable of accumulating TAG accoun-
ting for up to 76% of the cell dry weight (CDW) [1,7].
Unfortunately, these microorganisms generally exhibit a
rather slow growth rate and may require substantial and
challenging genetic modifications for higher TAG prod-
uctivity and/or for substrate utilization [8]. In this context,
TAG production in Escherichia coli may become a valid
alternative [9]. To date, a few recent studies have been
published describing engineered pathways for this neutral
lipid biosynthesis in E. coli [8,10,11]. These heterologous
routes are based on the production and accumulation of
the precursors, diacylglycerol (DAG) and fatty acyl-CoAs,
which are esterified to synthesize TAG by the activity of a
diacylglycerol acyltransferase (DGAT) (Figure 1). To raise
the intracellular DAG concentration in E. coli, two alter-
natives have been described: 1) the overexpression of the
native phosphatidylglycerol phosphate phosphatase PgpB
[8], or the heterologous expression of the phosphatidateFigure 1 Engineering E. coli for TAG biosynthesis. Heterologous protein
E. coli DgkA is labeled with a red cross. Sco0958, Lppβ, and ACC correspon
acetyl-CoA carboxylase enzymes from S. coelicolor, respectively. (1) Glycolytic p
(4) glycerol-3-P dehydrogenase; (5) glycerol-3-P and lysophosphatidic acid acy
synthase; TCA, tricarboxylic acid; MDO, membrane-derived oligosaccharide.phosphatase Lppβ from Streptomyces coelicolor [12]; and
2) the generation of a knockout mutant in the E. coli diac-
ylglycerol kinase gene, dkgA. Deletion of dgkA impairs the
recycling of the DAG generated during the synthesis of
membrane-derived oligosaccharides, thus leading to the
accumulation of the DAG moiety [13,14].
So far, TAG production in E. coli could be considered a
feasible development if the engineering process could lead
to a microorganism that accumulates TAG efficiently,
while maintaining its fast growth properties [9]. Thus, the
aim of this work was to construct a recombinant E. coli
strain that could synthesize and store high levels of this
neutral lipid. To do this we selected the two dedicated
TAG biosynthesis enzymes from S. coelicolor, the phospha-
tidic acid phospatase Lppβ and the acyl-CoA:diacylglycerol
acyltransferase Sco0958, and followed a modular engineer-
ing strategy to optimize their expression levels in the heter-
ologous host. Further genetic modifications introduced in
the TAG producer strain allowed us to obtain an E. coli
capable of accumulating the highest levels of TAG reported
for fed-batch fermentations.
Results and discussion
Impact of the S. coelicolor PAP activity in TAG
biosynthesis in E. coli
In previous work Comba et al. demonstrated that the
heterologous co-expression of the S. coelicolor DGATs expressed in E. coli are highlighted in color, and the knockout of the
d to diacylglycerol acyltransferase, phosphatidic acid phosphatase, and
athway; (2) acetyl-CoA carboxylase; (3) malonyl-CoA:ACP transacylase;
ltransferases; DHAP, dihydroxyacetone phosphate; FAS, fatty acid
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the PAP (phosphatidic acid phosphatase) Lppβ, in an E.
coli BL21 (DE3) strain leads to the production of TAG,
while the sole expression of Sco0958 is unable to induce
accumulation of this neutral lipid in the same genetic
background [12]. On the other hand, Arabolaza et al.
showed that the expression of the DGAT Sco0958 in an
E. coli strain containing a deletion in the dgkA gene is
sufficient to induce TAG accumulation [15], suggesting
that DAG is the limiting metabolite for TAG biosyn-
thesis in E. coli. To test if DAG was still a limiting factor
in a dgkA background, we evaluated the impact of Lppβ
in TAG biosynthesis in a BL21 ΔdgkA strain - named
strain MPS11 - in the presence of Sco0958. To do this
we transformed the MPS11 strain with plasmids pBAD-
0958, containing the SCO0958 gene under the PBAD pro-
moter, and pET28-LPPβ, which contains the lppβ gene
under the T7 promoter. As shown in Figure 2, the sole
expression of SCO0958 in the MPS11 strain was suf-
ficient to promote accumulation of significant levels of
TAG (Figure 2, lane 2). However, co-expression of both
the Sco0958 and Lppβ enzymes increases TAG produc-
tion by 1.6-fold (Figure 2, lane 4 versus lane 2). These re-
sults indicate that DAG availability is crucial for obtaining
higher neutral lipid yields and that the PAP activity of
Lppβ does help to circumvent this bottleneck in the
TAG biosynthesis pathway reconstructed in E. coli BL21.Figure 2 Radio-thin layer chromatography (TLC) of E. coli
MPS11/pBAD-0958/pET28-LPPβ total lipid extracts. Cultures
of E. coli were grown as described in Methods, and expression of
Sco0958 and Lppβ enzymes was induced with L-arabinose and IPTG,
respectively. Each lane contains the lipid extracts of 1 mg cell dry
mass, and the values indicated above represent the densitometry
measurement of TAG expressed in arbitrary units. TAG, triacylglycerol;
FA, fatty acids; DAG, diacylglycerol; PL, phospholipids.Interestingly, low levels of TAG biosynthesis were also
detected under conditions of no induction of either
SCO0958 or lppβ, or when only lppβ expression was in-
duced (Figure 2, lanes 1 and 3, respectively); this low level
of TAG production may occur by the leaky expression of
SCO0958 from PBAD or, as suggested by Rotering and
Raetz, by the existence of a hitherto unrecognized metab-
olism of minor neutral lipids biosynthesis in E. coli [16].
In this regard, the native E. coli phosphatidylglycerol
phosphate phosphatase, PgpB, has been used as a surro-
gate PAP for TAG production [8]. Specifically, in a re-
cent work Janssen and Steinbüchel described an E. coli
K12 strain capable of producing 0.3% of the cellular dry
mass of TAG by overexpressing PgpB and the fatty acyl-
CoA synthase FadD from E. coli plus the DGATAtfA from
Acinetobacter baylyi [11]. Although this pathway was not
reconstituted in a dgkA background, making a direct com-
parison with our approach somehow difficult, it is appro-
priate to highlight that PgpB is a broad substrate spectrum
enzyme, as demonstrated by its in vitro phosphatase ac-
tivities towards phosphatidylglycerol, phosphatidic acid,
lysophosphatidic acid, diacylglycerol pyrophosphate, and
undecaprenyl pyrophosphate [17-19], while Lppβ is a dedi-
cated PAP involved in generating DAG for TAG biosyn-
thesis in S. coelicolor [12].
Fine-tuning TAG biosynthesis genes expression
In order to optimize TAG production in our E. coli
platform, we examined the use of alternative promoters,
genes organization, and plasmid copy numbers to modu-
late the expression levels of SCO0958 and lppβ and to
evaluate their impact in TAG biosynthesis. To do this, we
constructed several expression vectors derived from plas-
mids pET28a or pBAD33 harboring either SCO0958 or
lppβ as independent transcription units or as part of a
bicistronic operon (Figure 3A). To analyze the levels of
TAG produced by the individual expression systems, the
corresponding plasmids were transformed into E. coli
MPS11 and isolated clones of each of the four recom-
binant strains used for production studies in shake flasks.
Figure 3B shows that the sole expression of SCO0958
from the strong T7 promoter notably increases TAG con-
tent in the cell respective to its expression from the PBAD
promoter, demonstrating that under these conditions
higher levels of the DGAT Sco0958 result in higher levels
of TAG biosynthesis (Figure 3B, compare columns 1b
and 2b). As expected, in all cases where the two genes
of the system were induced, TAG accumulation was fur-
ther improved, suggesting that the PAP Lppβ increases
the levels of DAG, which is otherwise a limiting meta-
bolite of the system. Maximal production of TAG was
reached by co-expressing SCO0958 from the strong T7
promoter and lppβ from PBAD (Figure 3B, column 2c). A
western blot analysis of Sco0958 and Lppβ expression for
Figure 3 Optimization of TAG biosynthesis in the MPS11 strain. A) Schematic representation of the plasmid systems used for modulating
SCO0958 and lppβ genes expression. The gray dot upstream of the target genes represents Shine-Dalgarno sequences and the size of the bended
arrows, the relative strength of the inducible PT7 or PBAD promoters. B) Cultures of E. coli MPS11 containing the different expression systems
(1 to 4) were grown as described in Methods section, and expression of the respective genes was induced with L-arabinose and/or isopropyl-
β-D-thiogalactopyranoside (IPTG). TAG content recovered from each of the cultures is expressed as percentage of cell dry weight mass (% CDW).
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struction 2, condition c of Figure 3 represents the opti-
mum protein levels to reach maximal TAG accumulation
(Additional file 1: Figure S1). Unexpectedly, the coupled
expression of the SCO0958-lppβ operon, either from PT7
or PBAD promoters, was accompanied by a medium to low
accumulation of TAG, suggesting that in either case the
relationship between Sco0958 and Lppβ was not optimal
(Figure 3B, columns 3b and 4b). In these single-plasmid
systems, the levels of expression of both enzymes are
lower compared to the situation where the SCO0958
and lppβ genes are located in two different plasmids
(Additional file 1: Figure S1), leading to a suboptimal
activity of the pathway. Overall, these results support
the notion that expression of SCO0958 and lppβ has to
be finely modulated in order to achieve optimal levels
of TAG biosynthesis. Further studies will be necessary
to better understand the basis of the transcription-
translation dynamics of these genes in both expression
systems.
Curiously, although the PBAD promoter is weaker than
PT7 and the p15A origin of replication has a lower copy
number than ColE1, the Lppβ protein levels in condition
2c are slightly higher than in condition 1c (Additional
file 1: Figure S1). Moreover, when both proteins are
expressed, the Sco0958 protein titer decreases compared
to the situation where it is induced alone. This effect
could be due to the high metabolic burden imposed on
the cell when two, instead of one, proteins are expressed
from strong promoters. In this sense, to further optimize
the TAG-producing strain MPS11/pET28-0958/pBAD-
LPPβ, we evaluated the inducer dose-response to find
the best L-arabinose concentration to reach maximalTAG content. Cultures of the producer strain were grown
in Luria-Bertani (LB) medium and induced with different
concentrations of L-arabinose (Figure 4, lanes 5 to 8).
TAG quantification carried out by LC-MS revealed that
0.1% of L-arabinose was the inducer concentration that
leads to the highest TAG content. Furthermore, to
evaluate a possible contribution from the catabolism of
L-arabinose in TAG production, we included a control
with an empty pBAD33 plasmid instead of the pBAD-
LPPβ vector. In these cultures, increasing concentra-
tions of L-arabinose had no effect on the final TAG
content (Figure 4, lanes 1 to 4).
In summary, the systematic studies carried out towards
optimizing the expression levels of the specific TAG bio-
synthesis genes led us to identify the most suitable strain,
MPS11/pET28-0958/pBAD-LPPβ, and gene induction con-
ditions, 100 μM IPTG and 0.1% L-arabinose, to reach a
maximal TAG production of 4.15% CDW.
Neutral lipid profile of engineered E. coli expressing
Sco0958 or AtfA
The AtfA enzyme from A. baylyi was the first member
of the thereafter designated WS/DGAT prokaryotic
family of proteins [20]. Heterologous expression of this
enzyme has been used for the production of fatty acid
methyl esters, waxes, and TAG in E. coli [3,8,21]. In order
to specifically evaluate the TAG biosynthesis capabilities
of AtfA and compare it with our producer strain contain-
ing Sco0958 as a DGAT, we cloned the atfA gene in the
pET28 expression vector, generating plasmid pET28-AtfA,
and transformed it into an MPS11 derivative strain har-
boring the pBAD-LPPβ plasmid. As shown in Figure 5,
AtfA expression led to a significant production of TAG,
Figure 4 TLC analysis of total lipid extracts from E. coli MPS11
derivative strains. Cultures of E. coli were grown as described in
Methods, and expression of Sco0958 and Lppβ enzymes was
induced with IPTG and L-arabinose, respectively. pBAD33 was used
as an empty plasmid control. Lipid pattern obtained after processing
1 mg cell dry mass visualized by Cu-phosphoric staining. L-Ara,
L-arabinose; TAG, triacylglycerol; FA, fatty acids; DAG, diacylglycerol.
Figure 5 Total lipid analysis of E. coli MPS11 strain expressing
either the Sco0958 or the AtfA DGAT enzymes, in combination
with Lppβ. Cultures of E. coli were grown and analyzed as described
in Methods. Lipid pattern obtained after processing 1 mg cell dry mass
visualized by Cu-phosphoric staining. L-Ara, L-arabinose; WE, wax esters;
TAG, triacylglycerol; FA, fatty acids; DAG, diacylglycerol.
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ters by their retention factor on the TLC plates. This result
agrees with previous reports where AtfA is confirmed to
be capable of synthesizing butyl esters in E. coli, even in
the absence of a supplemented alcohol [3]. Moreover, the
levels of TAG achieved with AtfA were 10.6% lower than
the ones obtained with Sco0958. Although expression of
AtfA could be optimized to increase TAG titers, these re-
sults suggest that Sco0958 has a higher specificity than
AtfA for TAG synthesis and, therefore, Sco0958 appears
to be a better candidate for TAG production in E. coli.
Metabolic engineering further improves TAG
accumulation
To further improve TAG titers in our recombinant strain,
we followed a classic metabolic engineering approach to
enhance the pools of substrates of the TAG biosynthesis
enzymes. To increase fatty acyl-CoA availability, we pro-
ceeded to engineer the fatty acid oxidation pathway of E.
coli through the overexpression of fadD and the disrup-
tion of fadE. FadD activates free fatty acids into the meta-
bolically active acyl-CoA thioesters [22], and FadE is an
acyl-CoA dehydrogenase that catalyzes the first step of
the β-oxidation cycle, the oxidation of an acyl-CoA to a
2-enoyl-CoA [23]. The co-expression of Sco0958 andLppβ enzymes in a BL21 ΔdgkA ΔfadE strain - named
the MPS13 strain - led to a 9% higher accumulation of
TAG compared with its parental strain MPS11. Unex-
pectedly, overexpression of FadD in the ΔdgkA ΔfadE
genetic background did not further increase the levels
of TAG (Additional file 1: Table S1). This result sug-
gests that under the conditions tested the native FadD
activity is sufficient to activate the available FAs to their
respective acyl-CoAs.
In order to further optimize TAG production in E. coli,
we decided to overexpress proteins involved in key steps
of the central carbon metabolism that could be working as
bottlenecks in the carbon flow towards TAG biosynthesis.
For this purpose we selected the MPS13/pBAD-LPPβ
strain and transformed it with several pET28-based vec-
tors for the co-expression of Sco0958 with the following
selected targets: 1) GpsA, a glycerol 3-phosphate (G3P)
dehydrogenase from S. coelicolor, which catalyzes the ge-
neration of G3P from the glycolysis intermediate dihy-
droxyacetone phosphate. This enzyme was selected based
on previous results that showed that expression of a
Saccharomyces cerevisiae G3P dehydrogenase in Brassica
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ond copy of SCO0958; 3) FadR, the dual transcriptional
regulator of fatty acid metabolism in E. coli [25,26]. FadR
is a repressor of the β-oxidation genes and an activator of
the fatty acid biosynthesis genes fabA and fabB. The selec-
tion of FadR was based on previous results where it was
shown that its overexpression in E. coli led to a significant
increase in fatty acid content [27]; 4) The acetyl-CoA
carboxylase complex (ACC) from S. coelicolor, constituted
by three subunits AccA2, AccB, and AccE, which gener-
ates the malonyl-CoA utilized for fatty acid chain elong-
ation [28,29]. The analysis of TAG accumulation in each
of the derivatives strains containing the combination of
genes described above indicated that neither gpsA, nor the
extra copies of SCO0958 or fadR improved the levels
of TAG obtained with the original system (4.52% CDW
in MPS13/pET28-0958/pBAD-LPPβ, Additional file 1:
Table S1). However, expression of the S. coelicolor ACC
complex led to a 7.3% increase in TAG production,
reaching a TAG content of 4.85% CDW (Additional file 1:
Table S1). ACC complex overexpression is expected to
increase FA synthesis, thus raising the levels of FA-
derivative lipids. In this context, ACC enzymes could
have a double role in TAG synthesis precursor supply,
since it would increase the availability of DAG -
through the increase of PA - and/or of the fatty acyl-
CoA precursors.
Several metabolic engineering efforts have been carried
out in E. coli in order to improve FA production, as they
are potential precursors for FA-derived hydrocarbons
[4,5,9,10,27,30-37]. However, little has been done in this
host to channel these FAs towards TAG biosynthesis. In
this sense, Lin et al. constructed an E. coli BL21 deriva-
tive strain carrying multiple combinations of deletions in
genes involved in central carbon flux [10]. Although they
successfully increased FA availability in some of their mu-
tant strains, they did not obtain a concomitant increase inFigure 6 Fed-batch cultivation of MPS15/pET28-0958-ACC/pBAD-LPPβ
samples were taken periodically for OD, glucose, and neutral lipids analysisTAG content when the TAG biosynthesis enzymes were
overexpressed [10]. These results confirm that additional
bottlenecks must be overcome to achieve higher TAG ti-
ters. Interestingly, Lin et al. did not use a PAP enzyme to
improve DAG availability in their hosts, which according
to our results is the main limiting metabolite for TAG
biosynthesis.
Fed-batch cultivation for high yield TAG production
Based on the results obtained in our batch culture stu-
dies, we selected the MPS13/pET28-0958-ACC/pBAD-
LPPβ strain for the optimization of TAG production in
high cell density fermentations. Before initiating these
studies, we introduced one additional mutation in the
producing strain in order to prevent L-arabinose meta-
bolization and thus avoid permanent feeding of the in-
ducer; to do this we knocked out the complete araBAD
operon in MPS13, giving rise to the BL21 ΔdgkA ΔfadE
ΔaraBAD, named the MPS15 strain. Fed-batch cultures
were performed in minimal medium, using glucose as
the carbon source, at 37°C. Heterologous protein pro-
duction was induced by addition of 1 mM IPTG and
L-arabinose 0.1% at OD600nm about 60 after shifting the
temperature of the process to 23°C to improve protein
solubility. Glucose was kept limiting throughout the
process in order to avoid overflow of the tricarboxylic
acid (TCA) cycle and the concomitant production of
acetate. Dissolved oxygen was maintained above 40% to
prevent anaerobic fermentation of the carbon source.
Samples were taken periodically for neutral lipids analysis.
Figure 6 shows the progression of the fed-batch cul-
tures carried out in this study. The complete process
took 68 h, and at the end of the fermentation, the
MPS15/pET28-0958-ACC/pBAD-LPPβ strain was able
to synthesize 722.1 mg TAG L-1, reaching a cell TAG
content of 2.83% CDW. Under these conditions, the
volumetric productivity was 10.54 mg TAG L-1 h-1 at thestrain. E. coli strain was cultured as described in Methods, and
.
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the resulting E. coli single cell oil was also analyzed and
is described in Additional file 1: Table S2. The most
abundant triglyceride species reflect the composition of
total E. coli FA, as they are composed mainly of saturated
and monounsaturated C16 and C18 FAs. Similar results
were reported by Rucker et al. by analyzing the FA com-
position of E. coli TAG grown in batch cultures [8].
To our knowledge, the only other study where TAG
production in E. coli was evaluated in fed-batch fermen-
tors is that from Janssen and Steinbüchel [11]. In their
work the authors used an E. coli K12 derivative strain
that reached a final OD600nm of 13.2 after 68 h and pro-
duced 532 mg L-1 TAG, with a maximal TAG content of
8.5% CDW under limited nitrogen conditions [11].
Although the maximal TAG content of strain MPS15/
pET28-0958-ACC/pBAD-LPPβ obtained during the fer-
mentation process was significantly lower than the ones
obtained in batch assays, the cultures grown in the reac-
tors were still able to produce the highest TAG titers re-
ported for E. coli until now. It is difficult to predict the
cause(s) of this striking difference in TAG accumulation
between the two different growth systems, although we
could speculate that the use of minimal medium in the
reactors, instead of LB, could account for such a diffe-
rence. However, we also observed that batch cultures of
the selected strain carried out in minimal medium sup-
plemented with 5 g L-1 glucose - which is below the ca-
tabolite repression threshold - have the same production
levels as the batch cultures grown in LB medium (data not
shown). Therefore, other bottlenecks or limitations ap-
pear to exist during fermentation that do not allow
higher accumulation of the neutral lipid. We speculate that
further improvements or optimization of the fermentation
process should let us reach the production levels that were
achieved in batch cultures.
Conclusions
In this work we described the successful reconstruction
of the S. coelicolor TAG biosynthesis pathway in the
model heterologous host E. coli. By genetically engineering
the E. coli producer strain, we improved the final TAG
content up to 4.85% CDW in batch cultures. Additionally,
the fed-batch microbial fermentation was also optimized,
achieving a maximum yield of 722.1 mg TAG L-1 and a
volumetric productivity of 10.54 mg TAG L-1 h-1. These
results represent the highest reported fed-batch produc-
tivity of TAG reached by a non-oleaginous heterologous
bacterium. However, the titer of TAG produced by this
recombinant E. coli is still low compared with those of
natural oleaginous producers such as Rhodococcus sp.
Considering the productivities of TAG reported for
fed-batch fermentations of Rhodococcus opaccus, much
basic research is needed in the E. coli system in orderto efficiently convert the high levels of FA that this organ-
ism can produce into higher concentrations of TAG or of
other high-value hydrocarbons of industrial interest.Methods
Media and growth conditions
E. coli strains were routinely grown either on solid or in
liquid LB medium at 37°C and supplemented when
needed with the following antibiotics: 100 μg mL-1 ampi-
cillin (Ap), 50 μg mL-1 kanamycin (Km), or 20 μg mL-1
chloramphenicol (Cm). For auxotrophy tests, M9 min-
eral media supplemented with either 0.2% glucose, 0.2%
L-arabinose, or 0.1% oleate/0.4% Brij 58 were used. For
solid media, 1.5% agar was added before autoclaving.
The minimal medium for fed-batch fermentation con-
sisted of 0.5 g L-1 yeast extract, 20.8 g L-1 KH2PO4, 3 g L
-1
(NH4)2HPO4, and 4 g L
-1 NaH2PO4. After autoclaving, it
was supplemented with 50 μg mL-1 Km, 20 μg mL-1 Cm,
1.5 mL of trace element solution per liter, and the cor-
responding amount of carbon source solution. The trace
element solution contained 50 mM FeCl3, 20 mM CaCl2,
10 mM ZnSO4, 10 mM MnCl2, 2 mM CoCl2, 2 mM
CuCl2, 2 mM NiCl2, 2 mM H3BO3, 2 mM Na2MoO4, and
2 mM Na2SeO3. The carbon source solution used con-
tained 600 g L-1 glucose and 15 g L-1 MgSO4.7H2O.Strain construction
All the strains used in this study are listed in Table 1.
The E. coli MPS11 strain was constructed by P1 trans-
duction of the dgkA::Km marker from the JW4002 strain
[38] to BL21 and subsequent FLP recombinase-mediated
excision of the kanamycin cassette as described by
Datsenko and Wanner [39]. The MPS13 strain was con-
structed by P1 transduction of the fadE::Km marker
from the JW5020 strain [38] to MPS11 and subsequent
FLP recombinase-mediated excision of the kanamycin
cassette [39]. The MPS14 strain was constructed by the
one-step inactivation of E. coli chromosomal genes de-
scribed by Datsenko and Wanner [39]. For this, ara-
BAD_F/araBAD_R oligonucleotides were used to amplify
the Km cassette of the pKD13 plasmid. The resulting
DNA fragment was used to transform MPS13/pKD46
electrocompetent cells to replace araBAD genes. The
kanamycin resistance cassette of strain MPS14 was de-
leted by FLP recombinase-mediated excision, yielding the
MPS15 strain [39]. Deletions of dgkA and fadE genes
were checked by PCR using dgkA_F/R and fadE_F/R pri-
mer pairs. Deletion of araBAD genes was checked by
PCR using ara_check_F/ara_check_R and araA_wt_F/
ara_check_R primer pairs. Knockout of fadE and araBAD
genes was also confirmed by growing the strains in M9
plates with glucose, arabinose, or oleate as sole carbon
sources.
Table 1 Strains and plasmids
Strain or plasmid Description Reference
Strains
DH5α E. coli K12 F- lacU169 (Φ80lacZΔM15) endA1 recA1 hsdR17 deoR supE44 thi-1 l2 gyrA96 relA1 [40]
BL21 (DE3) E. coli F- ompT gal dcm lon hsdSB(rB
- mB
- ) λ(DE3) Novagen
MPS10 BL21 (DE3) ΔdgkA::Km; KmR This study
MPS11 BL21 (DE3) ΔdgkA This study
MPS12 BL21 (DE3) ΔdgkA ΔfadE::Km; KmR This study
MPS13 BL21 (DE3) ΔdgkA ΔfadE This study
MPS14 BL21 (DE3) ΔdgkA ΔfadE ΔaraBAD::Km; KmR This study
MPS15 BL21 (DE3) ΔdgkA ΔfadE ΔaraBAD This study
Plasmids
pET28a Vector for expression of N-terminal His-tagged proteins under the strong T7 promoter; KmR Novagen
pBAD33 Vector for recombinant protein expression under the control of the PBAD promoter; Cm
R [41]
pKD13 Template plasmid for amplification of the FRT-flanked kanamycin cassette; ApR KmR [39]
pKD46 Temperature-sensitive replication plasmid for Red recombinase expression; ApR [39]
pCP20 Temperature-sensitive replication plasmid for thermal induction of FLP synthesis; CmR ApR [42]
pCR®-BluntII-TOPO Vector used for cloning of blunt PCR products; KmR Invitrogen
pBAD0958 pBAD33 carrying the SCO0958His gene under the control of PBAD promoter; Cm
R [15]
pET28-LPPβ pET28 carrying the SCO1753His gene under the control of T7 promoter; KmR [12]
pBAD-LPPβ pBAD33 carrying the SCO1753His gene under the control of PBAD promoter; Cm
R [12]
pTR257 pET28 carrying the SCO0958His gene under the control of T7 promoter; KmR [15]
pET28-0958- LPPβ pET28 carrying the SCO0958His-SCO1753His operon under the control of T7 promoter; KmR This study
pBAD-0958- LPPβ pBAD33 carrying the SCO0958His-SCO1753His operon under the control of PBAD promoter; CmR This study
pET28-AtfA pET28 carrying the atfAHis gene under the control of T7 promoter; KmR This study
pET28-FadD pET28 carrying the fadDHis gene under the control of T7 promoter; KmR This study
pET28-0958- FadD pET28 carrying the SCO0958His-fadDHis operon under the control of T7 promoter; KmR This study
pCC01 pET28 carrying the accA2His gene under the control of T7 promoter; KmR [43]
pET28-AccA2-AccE pET28 carrying the accA2His-accE His operon under the control of T7 promoter; KmR This study
pET28-AccA2-AccE-AccB pET28 carrying the accA2His-accEHis-accBHis operon under the control of T7 promoter; KmR This study
pET28-0958-ACC pET28 carrying the SCO0958His-accA2His-accEHis-accBHis operon under the control of T7 promoter; KmR This study
pET28-GpsA pET28 carrying the gpsAHis gene under the control of T7 promoter; KmR This study
pET28-0958-GpsA pET28 carrying the SCO0958His-gpsAHis operon under the control of T7 promoter; KmR This study
pET28-FadR pET28 carrying the fadRHis gene under the control of T7 promoter; KmR This study
pET28-0958-FadR pET28 carrying the SCO0958His-fadRHis operon under the control of T7 promoter; KmR This study
pET28-0958-0958 pET28 carrying the SCO0958His-SCO0958His operon under the control of T7 promoter; KmR This study
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All the plasmids used in this study are listed in Table 1.
The oligonucleotides used for PCR are listed in Table 2.
The pET28-0958-LPPβ vector was constructed by ligation
of the XbaI/HindIII digestion fragment of pET28-LPPβ
into SpeI/HindIII restriction sites of pTR257. The XbaI/
HindIII digestion fragment was then cloned in XbaI/
HindIII sites of pBAD33, yielding plasmid pBAD0958-LPPβ.
The atfA gene [GenBank:2879218] was amplified by PCR
from Acinetobacter sp. ADP1 genomic DNA using theatfA_F/atfA_R primer pair. The fadD [GenBank:8182496]
and fadR [GenBank:8181871] genes were amplified by PCR
from E. coli BL21 genomic DNA using the fadD_F/fadD_R
and fadR_F/fadR_R primer pairs, respectively. The gpsA
[GenBank:1101000], accB [GenBank:1100975], and accE
[GenBank:1100976] genes were amplified by PCR from
S. coelicolor genomic DNA using the gpsA_F/gpsA_R,
accB_F/accB_R and accE_F/accE_R primer pairs, res-
pectively. The resulting PCR products were cloned in
the pCR®-BluntII-TOPO vector and checked by DNA
Table 2 PCR oligonucleotides
Name Sequence (5′-3′) Reference
dgkA_F AGGATCTGCCGGAATAGACTTGCTT This study
dgkA_R AGCGCCTTCAGATGTTCTTCAGCC This study
fadE_F CAAAAGCGAGAAGTACGGGCAGGTG This study







ara_check_F TAAACGAGTATCCCGGCAGCAGGGG This study
ara_check _R CGGGAATAAACGCCACGGACTCTTG This study
araA_wt_F AAGTGTATTACGGGTTTCGTCGCTA This study
atfA_F CATATGCGCCCATTACATCCGATTG This study
atfA_R ACTAGTCCTTTAGTTTTATCTGATA This study
fadD_F GCTAGCAAGAAGGTTTGGCTTAACC This study
fadD_R ACTAGTCTCAGGCTTTATTGTCCAC This study
gpsA_F CATATGAGCAAGCCGGTCAAGGCGG This study
gpsA_R ACTAGTGCGGGTTGCGCGGGGGGTC This study
fadR_F CATATGGTCATTAAGGCGCAAAGCC This study
fadR_R ACTAGTATGGGAAATCTGTAAAAAC This study
accB_F CATATGACCGTTTTGGATGAGGCGC This study
accB_R ACTAGTTCACTGCGGCGGGTTGCCG This study
accE_F CATATGTCCCCTGCCGACATCCGCG This study
accE_R ACTAGTTCAGCGCCAGCTGTGCGGG This study
Restriction sites are shown in italics. Homologous sequences to pKD13 plasmid
are shown in bold.
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Facility, Orono, ME, USA). The AtfA, FadR, GpsA, AccB,
and AccE coding sequences were cloned in pET28a
as NdeI/EcoRI digestion fragments, yielding plasmids
pET28-AtfA, pET28-FadR, pET28-GpsA, pET28-AccB,
and pET28-AccE, respectively. fadD was cloned as an
NheI/EcoRI digestion fragment into pET28a, yielding
plasmid pET28-FadD.
The pET28-AccA2-AccE plasmid was constructed by
ligation of the XbaI/HindIII digest of pET28-AccE into
SpeI/HindIII sites of pCC01. The XbaI/HindIII digestion
fragment of pET28-AccB was then cloned into SpeI/
HindIII sites of pET28-AccA2-AccE, yielding plasmid
pET28-AccA2-AccE-AccB. This plasmid carries the cod-
ing sequences for the complete acetyl-CoA carboxylase
complex of S. coelicolor.
pET28a derivative vectors carrying the FadD, AccA2-
AccE-AccB, FadR, GpsA, and SCO0958 coding sequen-
ces were digested with XbaI/HindIII restriction enzymes,
and the resulting fragments were cloned into SpeI/
HindIII sites of pTR257, yielding plasmids pET28-0958-
FadD, pET28-0958-ACC, pET28-0958-FadR, pET28-
0958-GpsA, and pET28-0958-0958, respectively.Total lipid analysis
Batch cultures of E. coli strains were grown in LB media
at 37°C until OD600nm was about 0.6. Then, protein
expression was induced by addition of IPTG and/or
L-arabinose. When the E. coli strain harbored pET28-
LPPβ and pBAD-0958 plasmids, L-arabinose was first
added at OD600nm 0.6 and IPTG was added 1 h later.
After induction, the cultures were kept overnight at
23°C with agitation. For 14C labeled experiments 3 μCi
[14C]-acetate (58.9 Ci/mol, Perkin Elmer) was added to
5 mL of culture, at the same time as the protein induc-
tion. Cultures were then normalized by CDW and total
lipids were extracted as described by Bligh and Dyer [44].
The lipid extracts were dried and analyzed by TLC on sil-
ica gel 60 F254 plates (0 ± 2 mm, Merck), using the solvent
systems hexane/diethylether/acetic acid (75:25:1, v/v/v)
[16]. Lipid fractions were visualized by Cu-phosphoric
staining and identified by comparing to the mobility of
known standards. For 14C labeled lipids the radioactivity
incorporated into each lipid fraction was detected by auto-
radiography using Carestream® Kodak® BioMax® MR films.
All the TLC plates were digitalized and the spots were
quantified using ImageJ v1.48 software.
SDS-PAGE and immunoblot
SDS-PAGE and immunoblot analyses using nitrocellu-
lose membranes were carried out using standard proto-
cols [45,46]. For detection of the His-tagged proteins,
mouse monoclonal anti-His antibodies (QIAGEN™) were
used at a dilution of 1:1000. Anti-mouse IgG-alkaline
phosphatase conjugates were used as secondary anti-
bodies at a dilution of 1:3000. His-tagged proteins were
visualized by immunoblots using chromogenic detection
as described by the manufacturer.
Triacylglycerol quantification by high resolution LC-MS
For quantification of triacylglycerides, the biomass was
lyophilized and weighed, and 1 mg was processed for
total lipid extraction as described by Bligh and Dyer
[44]. 10 μg of cetyl palmitate was added before ex-
traction as an internal standard for load control. Then
500 μL of chloroform were added to solubilize lipids and
50 μL of the lipid extract were diluted in an equal part of
methanol. 5 μL of this solution were injected and separated
on a ZORBAX Eclipse XDB-C8 column (3.0 × 50 mm,
particle size =1.8 μm; Agilent, USA) using methanol sup-
plemented with 5 mM ammonium acetate as the mo-
bile phase. The outlet of the liquid chromatograph was
connected to a micrOTOF mass spectrometer (Bruker
Daltonik, Bremen, Germany) operating in the positive-
ion mode, and the data was acquired online in the mass
range m/z 300-1500. TAGs were detected as ammo-
nium adducts in the range of 6-20 min of the chroma-
tography run. A calibration curve was done using pure
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the samples was calculated by the linear regression
equation obtained from the calibration curve.
Fed-batch cultivation
A BioFLO 110 2 Lt Fermentor/Bioreactor (New Brunswik
Scientific®) containing 0.9 L of minimal medium described
above was autoclaved at 121°C for 30 min. After steriliza-
tion, 50 mg Km, 20 mg Cm, 20 g glucose, 0.5 g MgSO4.
7H2O, and 1.5 mL trace element solution were added
aseptically to the bioreactor. The reactor temperature, pH,
and dissolved oxygen (DO2) were monitored using specific
probes (Mettler-Toledo®). The temperature was main-
tained at 37°C or 23°C using a heat blanket and cooling
water. The reactor pH was maintained at 7.0 ± 0.1 by the
addition of 15% (v/v) NH4OH. When the ammonium con-
centration reached 200 mM, 15% NH4OH was replaced
by 5 M NaOH. Agitation was provided by a double six-
bladed impeller with the stir speed set at 700 rpm, and the
gas flow was alternated between air and oxygen to ensure
that the DO2 content did not decrease below 40% satu-
ration. The gas inflow rate was maintained at 0.33 vvm.
Foaming was controlled by the addition of Antifoam A
(Code A5633, Sigma-Aldrich®). The glucose and ammo-
nium concentrations were measured with enzymatic kits
from Wiener Lab®, codes 1400101 and 1810050, respec-
tively. Inoculation was carried out at 37°C with 100 mL of
seed culture at OD600nm approximately 2. When glucose
in the initial medium was depleted at 12 h after inocula-
tion (OD600nm about 20), a nutrient feed consisting of the
described carbon source solution was initiated at a fixed
rate of 0.2 mL/min. When the culture reached OD600nm
about 60, 16 h after inoculation, the temperature was re-
duced to 23°C, the nutrient feed rate was shifted to a fixed
rate of 0.1 mL/min, and heterologous protein expression
was induced by the addition of 100 μM IPTG and 0.1%
(w/v) L-arabinose. The culture was allowed to continue
until maximum TAG production was reached (68.5 h).
TAG production (mg TAG/L), at a given time point, was
calculated from the TAG content of the corresponding
sample, considering the current OD600nm and volume of
the sample, and the current volume of the fed-batch cul-
ture at this time point.Additional file
Additional file 1: Figure S1. Western blot analysis of Sco0958 and
Lppβ in the strains described in Figure 3. Protein extracts were resolved
by SDS-PAGE in a 12% polyacrylamide gel and detected by immunoblotting
using anti-His antibodies as described in the Methods section. Lane 1,
MPS11; lanes 2 and 3, MPS11/pBAD-0958/pET28-LPPβ; lanes 4 and 5,
MPS11/pET28-0958/pBAD-LPPβ; lane 6, MPS11/pET28-0958-LPPβ; lane 7,
MPS11/pBAD-0958-Lppβ. Table S1. Cell TAG content of different E. coli
strains determined by high resolution LC-MS. Table S2. E. coli triglyceride
fatty acid relative composition.Abbreviations
Ara: arabinose; CDW: cell dry weight; DAG: diacylglycerol;
DGAT: diacylglycerol acyltransferase; FA: fatty acid; IPTG: isopropyl-β-D-
thiogalactopyranoside; LC-MS: liquid chromatography coupled to mass
spectrometry; OD: optical density; PAP: phosphatidic acid phosphatase;
PL: phospholipid; TAG: triacylglycerol, triglyceride; TLC: thin layer
chromatography.
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